We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Dancing vs dueling

15 January 2010 By Robert Cyran

The $14 bln U.S. biotech is getting a muchneeded shakeup. Relational Investors is backing management for now. But Carl Icahn, with a history of forcing companies into auctions, hovers. A sale might book a quick gain but a smaller, more focused firm would be more valuable.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)